import React from 'react';
import { motion } from 'framer-motion';
import { Button } from '@/components/ui/button';
import { Link } from 'react-router-dom';
import { createPageUrl } from '@/utils';
import { ArrowLeft, BookOpen, FlaskConical, Microscope, GraduationCap, Beaker, Dna, Brain, Heart, Shield, Zap, Activity, Flame, Sun } from 'lucide-react';
import SEO from '@/components/SEO';

const blogPosts = [
  {
    id: 'bpc-157-research-guide',
    title: 'BPC-157 Research Guide: Everything You Need to Know',
    excerpt: 'Comprehensive research overview of Body Protection Compound-157 (BPC-157), including molecular structure, reconstitution protocols, storage requirements, and current scientific literature on tissue repair mechanisms.',
    date: '2026-01-28',
    readTime: '12 min read',
    icon: FlaskConical,
    keywords: 'BPC-157 research, body protection compound, tissue repair peptide, BPC-157 reconstitution',
    content: `
# BPC-157 Research Guide: Comprehensive Laboratory Overview

## Introduction to BPC-157

Body Protection Compound-157 (BPC-157) is a synthetic peptide derived from a protective protein found in gastric juice. This 15-amino acid peptide sequence has become a focal point in peptide research due to its unique molecular characteristics and potential tissue repair mechanisms.

## Molecular Structure and Properties

**Chemical Formula:** C₆₂H₉₈N₁₆O₂₂
**Amino Acid Sequence:** GEPPPGKPADDAGLV
**Molecular Weight:** ~1,419.55 Da
**Sequence Length:** 15 amino acids
**CAS Number:** 137525-51-0
**Stability:** Highly stable synthetic peptide, remains intact in gastric juice for 24+ hours
**Solubility:** Water-soluble, compatible with bacteriostatic water reconstitution

## Reconstitution Protocol for Research

### Standard Laboratory Reconstitution:
1. **Materials Required:**
   - Lyophilized BPC-157 vial
   - Bacteriostatic water (sterile water with 0.9% benzyl alcohol)
   - Sterile syringe and needle
   - Alcohol wipes

2. **Step-by-Step Process:**
   - Calculate desired concentration (typically 250mcg/mL to 1mg/mL)
   - Draw appropriate volume of bacteriostatic water
   - Inject water slowly down the vial wall (avoid foaming)
   - Gently swirl (do NOT shake vigorously)
   - Allow to dissolve completely (2-5 minutes)
   - Inspect for clarity and complete dissolution

3. **Storage Requirements:**
   - Refrigerate at 2-8°C (36-46°F)
   - Protect from light (amber vial or wrapped)
   - Shelf life: 30-60 days when properly stored
   - Freeze at -20°C for extended storage (up to 6 months)

## Current Research Applications

### Published Studies Focus Areas:
- **Tissue Repair Mechanisms:** Investigation of BPC-157's effects on cellular proliferation and tissue regeneration
- **Gut-Brain Axis:** Research into gastric protection and intestinal barrier function
- **Musculoskeletal Research:** Studies on tendon, ligament, and muscle tissue repair pathways
- **Neuroprotection:** Emerging research on neural tissue protection mechanisms

### Typical Research Dosing Parameters:
*Note: These are research parameters from published studies, not recommendations*
- Concentration range: 200-500 mcg/mL
- Common volumes: 1-3mL bacteriostatic water per 5mg vial
- Research protocols typically use subcutaneous administration in animal models

## Quality Control and Verification

### Laboratory Testing Standards:
- **Purity Testing:** HPLC analysis (≥98% purity standard)
- **Mass Spectrometry:** Molecular weight verification
- **Certificate of Analysis (COA):** Third-party lab verification
- **Endotoxin Testing:** LAL assay for bacterial contamination
- **Sterility Testing:** USP <71> compliance

## Research Safety Considerations

**IMPORTANT DISCLAIMER:** BPC-157 is intended for laboratory research use only. It is NOT intended for human consumption, therapeutic use, or veterinary applications. This information is provided for educational purposes to support legitimate scientific research.

### Laboratory Handling Protocols:
- Use appropriate PPE (gloves, lab coat, safety glasses)
- Work in a sterile environment (laminar flow hood when possible)
- Follow institutional biosafety protocols
- Proper sharps disposal procedures
- Material Safety Data Sheet (MSDS) compliance

## Emerging Research Directions

### Current Scientific Interest:
1. **Cellular Signaling Pathways:** Research into growth factor modulation
2. **Angiogenesis Mechanisms:** Blood vessel formation studies
3. **Inflammatory Response Modulation:** Cytokine pathway research
4. **Collagen Synthesis:** Extracellular matrix formation research

### Future Research Opportunities:
- Combination protocols with other peptides (e.g., TB-500)
- Tissue-specific repair mechanism elucidation
- Dosing optimization studies
- Long-term stability and efficacy research

## Ordering BPC-157 for Research

When sourcing BPC-157 for legitimate research purposes:
- ✓ Verify third-party COA availability
- ✓ Confirm HPLC purity ≥98%
- ✓ Check proper packaging (lyophilized powder in sterile vial)
- ✓ Ensure supplier provides batch-specific documentation
- ✓ Verify proper shipping conditions (temperature-controlled)

## Conclusion

BPC-157 represents a compelling area of peptide research with extensive published literature on tissue repair mechanisms. Proper handling, reconstitution, and storage protocols are essential for maintaining peptide integrity in laboratory settings. Researchers should always prioritize quality verification through third-party COAs and adhere to institutional research protocols.

**For Research Use Only** - Red Helix Research provides lab-tested BPC-157 with verified third-party Certificates of Analysis for legitimate scientific research.
    `
  },
  {
    id: 'tb-500-research-overview',
    title: 'TB-500 (Thymosin Beta-4) Research Overview',
    excerpt: 'In-depth research guide on TB-500 peptide, including molecular characteristics, cellular protection mechanisms, reconstitution protocols, and comprehensive review of scientific literature.',
    date: '2026-01-25',
    readTime: '15 min read',
    icon: Microscope,
    keywords: 'TB-500 research, thymosin beta-4, cellular protection peptide, TB-500 protocol',
    content: `
# TB-500 (Thymosin Beta-4) Research Overview

## What is TB-500?

TB-500 is the synthetic version of Thymosin Beta-4 (Tβ4), a naturally occurring 43-amino acid peptide found in high concentrations in wound healing fluid, blood platelets, and various tissues throughout the body. It represents one of the most extensively researched peptides in cellular protection and tissue regeneration.

## Molecular Structure

**Full Name:** Thymosin Beta-4
**Molecular Formula:** C₂₁₂H₃₅₀N₅₆O₇₈S
**Molecular Weight:** ~4,963 Da
**Amino Acid Sequence Length:** 43 amino acids
**Key Active Motif:** LKKTETQ (residues 17-23, the actin-binding domain)
**Stability:** Highly stable, resistant to degradation
**Solubility:** Excellent water solubility
**Storage:** Requires refrigeration (2-8°C) after reconstitution

## Mechanisms of Action (Research Findings)

### Published Research Highlights:
1. **Cellular Migration and Proliferation:** Studies demonstrate TB-500's role in cell movement and tissue formation
2. **Actin Regulation:** TB-500 binds to actin, a crucial protein in cell structure and movement
3. **Anti-Inflammatory Properties:** Research shows modulation of inflammatory cytokines
4. **Angiogenesis Promotion:** Studies on new blood vessel formation mechanisms
5. **Stem Cell Differentiation:** Research into tissue-specific cell development

## Laboratory Reconstitution Protocol

### Standard Research Protocol:
**For 5mg TB-500 vial:**

1. **Materials Needed:**
   - TB-500 lyophilized powder (5mg)
   - Bacteriostatic water (2-3mL)
   - Sterile syringe (3mL capacity)
   - Alcohol prep pads
   - Sharps disposal container

2. **Reconstitution Steps:**
   
   Step 1: Sanitize work area and wash hands thoroughly
   Step 2: Remove caps from TB-500 vial and bacteriostatic water
   Step 3: Wipe both rubber stoppers with alcohol
   Step 4: Draw 2.5mL bacteriostatic water into syringe
   Step 5: Inject water slowly down the vial wall (45-degree angle)
   Step 6: Gently rotate vial (do NOT shake)
   Step 7: Allow 3-5 minutes for complete dissolution
   Step 8: Inspect for clarity - should be clear with no particles

3. **Final Concentration:** 2mg/mL (5mg in 2.5mL)

### Storage Guidelines:
- **Unreconstituted:** Room temperature (15-25°C) acceptable, refrigeration preferred
- **Reconstituted:** 2-8°C mandatory (refrigerator)
- **Shelf Life:** 30 days refrigerated, 90 days frozen (-20°C)
- **Light Protection:** Store in original amber vial or wrap in aluminum foil

## Research Applications

### Published Study Focus Areas:

**Cardiovascular Research:**
- Cardiac tissue repair following injury
- Myocardial cell survival mechanisms
- Coronary vessel development studies
- Post-ischemic tissue recovery research

**Musculoskeletal Research:**
- Muscle fiber regeneration pathways
- Tendon and ligament healing mechanisms
- Connective tissue repair research
- Exercise-induced tissue damage studies

**Neurological Research:**
- Neural cell protection mechanisms
- Neurite outgrowth studies
- Brain injury recovery research
- Cognitive function preservation studies

**Wound Healing Research:**
- Dermal tissue repair mechanisms
- Collagen deposition studies
- Extracellular matrix formation
- Chronic wound healing research

## Research Dosing Parameters

*Data from published animal model studies:*

**Typical Research Concentrations:**
- Low dose: 1-2mg per administration
- Moderate dose: 2-5mg per administration
- High dose: 5-10mg per administration

**Frequency in Studies:**
- Acute protocols: 2-3x per week
- Intensive protocols: Daily for initial phase
- Maintenance protocols: 1-2x per week
- Duration: 4-12 weeks in most studies

## Quality Control and Verification

### Essential Lab Testing:
1. **HPLC Analysis:** High-Performance Liquid Chromatography for purity verification (target ≥98%)
2. **Mass Spectrometry:** Molecular weight confirmation (~4,963 Da)
3. **Amino Acid Analysis:** Sequence verification
4. **Endotoxin Testing:** LAL (Limulus Amebocyte Lysate) assay
5. **Sterility Testing:** USP <71> compliance
6. **pH Testing:** Optimal range 5.5-7.5

### Certificate of Analysis (COA) Requirements:
- Batch number and date of manufacture
- Purity percentage (minimum 98%)
- Molecular weight confirmation
- Sterility test results
- Endotoxin levels (<10 EU/mg)
- Storage and handling recommendations

## Safety and Handling in Research Settings

**Laboratory Protocols:**
- Biosafety Level 1 (BSL-1) minimum
- Personal Protective Equipment (PPE) required
- Laminar flow hood recommended for preparation
- Proper sharps disposal (puncture-resistant container)
- Spill cleanup procedures documented
- Material Safety Data Sheet (MSDS) readily available

**REGULATORY DISCLAIMER:** TB-500 is strictly for laboratory research purposes only. It is not approved by the FDA for human use, therapeutic treatment, or veterinary applications. This information is provided solely for educational purposes to support legitimate scientific research.

## TB-500 vs BPC-157: Research Comparison

### Complementary Mechanisms:
- **TB-500:** Systemic cellular protection and migration
- **BPC-157:** Localized tissue repair and regeneration
- **Stacking Potential:** Research suggests complementary pathways

### Key Differences:
| Parameter | TB-500 | BPC-157 |
|-----------|---------|---------|
| Molecular Weight | ~4,963 Da | ~1,494 Da |
| Amino Acids | 43 | 15 |
| Primary Focus | Cellular protection | Tissue repair |
| Mechanism | Actin-binding | Growth factor modulation |
| Research Frequency | 2-3x weekly | Daily in studies |

## Emerging Research Directions

### Current Scientific Interest (2025-2026):
1. **Cardiac Repair Research:** Post-myocardial infarction recovery studies
2. **Athletic Performance Research:** Tissue adaptation and recovery mechanisms
3. **Aging Research:** Cellular senescence and regenerative capacity
4. **Combination Protocols:** Synergistic effects with other peptides

### Future Research Opportunities:
- Tissue-specific delivery mechanisms
- Optimal dosing and frequency determination
- Long-term safety and efficacy studies
- Clinical translation potential assessment

## Sourcing TB-500 for Research

### Checklist for Research-Grade Peptides:
- ✓ Third-party COA with batch-specific data
- ✓ HPLC purity ≥98%
- ✓ Proper packaging (sterile, lyophilized)
- ✓ Temperature-controlled shipping
- ✓ Supplier transparency and communication
- ✓ Institutional research compliance

## Conclusion

TB-500 (Thymosin Beta-4) represents a cornerstone of peptide research with decades of published scientific literature supporting its cellular protection mechanisms. Proper reconstitution, handling, and storage are critical for maintaining peptide integrity in laboratory research settings.

Researchers conducting legitimate studies should prioritize quality verification, adhere to institutional protocols, and maintain comprehensive documentation of all procedures.

**Red Helix Research provides lab-tested TB-500 with verified third-party Certificates of Analysis for legitimate scientific research purposes only.**
    `
  },
  {
    id: 'semaglutide-research-applications',
    title: 'Semaglutide Research Applications and Lab Protocols',
    excerpt: 'Detailed research guide on Semaglutide GLP-1 agonist, including molecular structure, metabolic research applications, reconstitution protocols, and comprehensive scientific literature review.',
    date: '2026-01-20',
    readTime: '14 min read',
    icon: GraduationCap,
    keywords: 'semaglutide research, GLP-1 research, metabolic peptide, semaglutide protocol',
    content: `
# Semaglutide Research Applications and Laboratory Protocols

## Introduction to Semaglutide

Semaglutide is a synthetic glucagon-like peptide-1 (GLP-1) receptor agonist that has revolutionized metabolic and endocrine research. This 31-amino acid modified peptide demonstrates remarkable stability and prolonged activity, making it an ideal subject for laboratory investigation of metabolic pathways and glucose regulation mechanisms.

## Molecular Characteristics

**Classification:** GLP-1 Receptor Agonist  
**Molecular Weight:** ~4,113 Da  
**Amino Acid Length:** 31 amino acids (modified GLP-1 analog)  
**Half-Life:** Extended (approximately 165 hours in vivo)  
**Modifications:** Includes fatty acid chain for albumin binding  
**Stability:** Highly stable peptide structure  

## Mechanism of Action (Research Findings)

### GLP-1 Receptor Pathway Research:

**Primary Mechanisms Studied:**
1. **Glucose-Dependent Insulin Secretion:** Research demonstrates enhancement of pancreatic beta-cell insulin release in response to glucose
2. **Glucagon Suppression:** Studies show reduction in hepatic glucose production via glucagon pathway inhibition
3. **Gastric Emptying Modulation:** Research on delayed gastric motility and satiety signaling
4. **Central Appetite Regulation:** Studies on hypothalamic appetite center modulation
5. **Cardiovascular Effects:** Research on cardioprotective mechanisms independent of weight changes

### Published Clinical Research Highlights:
- SUSTAIN clinical trial series (metabolic outcomes)
- STEP clinical trial series (weight management research)
- Cardiovascular outcome trials (CVOT data)
- Renal protection mechanism studies

## Laboratory Reconstitution Protocol

### Standard Research Preparation for 5mg Semaglutide:

**Materials Required:**
- Semaglutide lyophilized powder (5mg vial)
- Bacteriostatic water for injection (2-4mL)
- Sterile syringe and needle (3mL capacity)
- Alcohol preparation pads
- Refrigerated storage container

**Step-by-Step Reconstitution:**

1. Preparation Phase:
   - Bring peptide to room temperature (15-20 minutes)
   - Sanitize work surface with 70% isopropyl alcohol
   - Wash hands thoroughly and don sterile gloves

2. Reconstitution Phase:
   - Draw 2.5mL bacteriostatic water into syringe
   - Insert needle into vial at 45-degree angle
   - Inject water slowly down the vial wall (avoid direct stream onto powder)
   - Remove needle and gently rotate vial (do NOT shake)
   - Allow 5-10 minutes for complete dissolution
   
3. Verification Phase:
   - Inspect for complete clarity (no particles or cloudiness)
   - Check for proper dissolution
   - Label vial with reconstitution date and concentration

**Final Concentration:** 2mg/mL (5mg in 2.5mL)  
**Alternative:** 1.25mg/mL (5mg in 4mL) for lower concentration needs

### Storage Requirements:

**Unreconstituted Powder:**
- Temperature: 2-8°C (refrigerated)
- Protection: Keep in original packaging, protect from light
- Shelf life: Check manufacturer COA (typically 24-36 months)

**Reconstituted Solution:**
- Temperature: 2-8°C (must refrigerate)
- Protection: Amber vial or foil wrap (light-sensitive)
- Shelf life: 30 days maximum
- Do NOT freeze
- Discard if cloudiness or discoloration occurs

## Research Applications and Study Areas

### Metabolic Research:

**Glucose Metabolism Studies:**
- Insulin sensitivity modulation research
- Beta-cell function preservation studies
- Hepatic glucose production research
- Peripheral glucose uptake mechanisms

**Lipid Metabolism Research:**
- Adipocyte differentiation and function
- Lipolysis pathway investigation
- Lipid oxidation mechanism studies
- Triglyceride metabolism research

### Weight Management Research:

**Energy Balance Studies:**
- Appetite regulation at hypothalamic level
- Satiety signal transduction pathways
- Energy expenditure modulation research
- Body composition change mechanisms

**Gastrointestinal Research:**
- Gastric emptying rate studies
- GI hormone secretion modulation
- Nutrient absorption timing research
- Gut-brain axis communication pathways

### Cardiovascular Research:

**Cardioprotection Mechanism Studies:**
- Direct myocardial effects independent of weight loss
- Vascular endothelial function research
- Blood pressure regulation mechanisms
- Atherosclerotic plaque stability research

### Neuroprotection Research:

**Emerging Research Areas:**
- GLP-1 receptors in central nervous system
- Neurodegenerative disease mechanism research
- Cognitive function preservation studies
- Neuroprotective pathway elucidation

## Research Dosing Parameters

*Data from published research studies (animal models and clinical trials):*

**Typical Research Dosing Escalation:**
- **Week 1-4:** Low dose initiation (0.25mg equivalent)
- **Week 5-8:** Dose escalation (0.5mg equivalent)
- **Week 9-12:** Therapeutic dose (1.0mg equivalent)
- **Week 13+:** Maintenance or higher dose (1.7-2.4mg equivalent)

**Administration Parameters in Research:**
- Frequency: Once weekly (due to extended half-life)
- Route: Subcutaneous in animal models
- Site: Rotated administration sites in protocols
- Timing: Consistent day/time for pharmacokinetic consistency

## Quality Control and COA Verification

### Essential Testing for Research-Grade Semaglutide:

**Purity Analysis:**
- HPLC testing: ≥98% purity required
- Mass spectrometry: Molecular weight confirmation (~4,113 Da)
- Peptide mapping: Sequence verification
- Impurity profiling: Related substances <2%

**Safety Testing:**
- Endotoxin testing: LAL assay (<10 EU/mg)
- Sterility testing: USP <71> compliance
- pH testing: Range 7.4-8.0
- Osmolality testing: Physiological range

**Stability Testing:**
- Accelerated stability studies
- Real-time stability data
- Temperature stress testing
- Freeze-thaw cycle testing

## Research Safety and Compliance

**CRITICAL DISCLAIMER:** Semaglutide is intended strictly for laboratory research purposes only. It is not approved for human consumption outside of FDA-approved pharmaceutical products. This information is provided for educational purposes to support legitimate scientific research.

**Laboratory Handling Protocols:**
- Biosafety Level 1 (BSL-1) minimum requirements
- Personal Protective Equipment (PPE) mandatory:
  - Nitrile gloves (latex-free)
  - Lab coat or protective clothing
  - Safety glasses
- Sharps disposal in puncture-resistant containers
- Spill kit readily available
- Emergency eyewash station accessible
- Material Safety Data Sheet (MSDS) on file

## Semaglutide vs Tirzepatide: Research Comparison

### Receptor Selectivity:
- **Semaglutide:** GLP-1 receptor agonist (single pathway)
- **Tirzepatide:** GLP-1 + GIP dual agonist (dual pathway)

### Research Implications:
| Parameter | Semaglutide | Tirzepatide |
|-----------|-------------|-------------|
| Molecular Weight | ~4,113 Da | ~4,813 Da |
| Receptor Targets | GLP-1 only | GLP-1 + GIP |
| Half-Life | ~165 hours | ~120 hours |
| Research Focus | Metabolic studies | Enhanced metabolic studies |
| Clinical Efficacy | Strong | Stronger in trials |

**Note:** These peptides should NEVER be combined in research due to overlapping mechanisms and potential for excessive pathway activation.

## Emerging Research Directions (2025-2026)

### Current Scientific Interest:

**Neuroprotection Studies:**
- Alzheimer's disease mechanism research
- Parkinson's disease pathway investigation
- Cognitive decline prevention studies
- Brain GLP-1 receptor function research

**Cardiovascular Research:**
- Heart failure mechanism studies
- Ischemia-reperfusion injury research
- Vascular remodeling investigations
- Cardioprotective pathway elucidation

**Metabolic Disease Research:**
- NAFLD/NASH mechanism studies
- Insulin resistance pathway research
- Beta-cell preservation studies
- Metabolic flexibility investigations

### Future Research Opportunities:
- Tissue-specific GLP-1 receptor effects
- Long-term metabolic adaptation mechanisms
- Combination therapy research (with other peptides)
- Novel delivery system development
- Pharmacogenomic response prediction

## Sourcing Research-Grade Semaglutide

### Critical Checklist for Researchers:

**Quality Verification:**
- ✓ Third-party COA with batch-specific testing
- ✓ HPLC purity ≥98%
- ✓ Mass spectrometry confirmation
- ✓ Sterility and endotoxin testing documentation

**Supplier Evaluation:**
- ✓ Transparent communication and documentation
- ✓ Temperature-controlled shipping (<8°C)
- ✓ Proper packaging (lyophilized in sterile vial)
- ✓ Regulatory compliance documentation
- ✓ Customer support for technical questions

**Institutional Compliance:**
- ✓ IRB or IACUC approval (if applicable)
- ✓ Proper procurement documentation
- ✓ Storage facility verification
- ✓ Waste disposal protocols established

## Conclusion

Semaglutide represents a powerful tool for metabolic and endocrine research with extensive published literature supporting its mechanisms of action. The peptide's stability and well-characterized pharmacology make it ideal for laboratory investigation of GLP-1 pathways, glucose metabolism, weight regulation, and emerging neuroprotective mechanisms.

Researchers must prioritize quality verification through comprehensive COAs, maintain proper storage and handling protocols, and ensure institutional compliance with all applicable regulations.

**Red Helix Research provides pharmaceutical-grade, lab-tested Semaglutide with verified third-party Certificates of Analysis for legitimate scientific research purposes only. All products are for research use only and not intended for human consumption.**

---

**References Available Upon Request**  
*This guide is intended for educational purposes only. Always consult institutional research protocols and regulatory guidelines.*
    `
  },
  {
    id: 'peptide-reconstitution-complete-guide',
    title: 'Complete Peptide Reconstitution Guide for Research Labs',
    excerpt: 'Master guide to peptide reconstitution: bacteriostatic water ratios, sterile technique, storage protocols, concentration calculations, and troubleshooting for all research peptides.',
    date: '2026-01-15',
    readTime: '18 min read',
    icon: BookOpen,
    keywords: 'peptide reconstitution guide, bacteriostatic water, peptide storage, peptide mixing protocol',
    content: `
# Complete Peptide Reconstitution Guide for Research Laboratories

## Introduction

Proper reconstitution of lyophilized peptides is critical for maintaining peptide integrity, activity, and reproducibility in research studies. This comprehensive guide covers all aspects of peptide reconstitution from basic principles to advanced techniques.

## Understanding Lyophilized Peptides

### What is Lyophilization?

Lyophilization (freeze-drying) is the process of removing water from peptide solutions under vacuum, creating a stable powder form. This method:
- Extends shelf life significantly
- Maintains peptide structure and activity
- Facilitates transportation and storage
- Reduces degradation and oxidation

### Why Reconstitution is Critical:

**Quality Factors Affected:**
1. Peptide solubility and dispersion
2. Concentration accuracy for research
3. Sterility maintenance
4. Long-term stability
5. Experimental reproducibility

## Essential Materials and Equipment

### Required Materials:

**Solvents:**
- **Bacteriostatic Water (0.9% Benzyl Alcohol)** - Primary choice for most peptides
- **Sterile Water** - Alternative for short-term use
- **Acetic Acid (0.1M)** - For poorly soluble peptides
- **DMSO** - For highly hydrophobic peptides (use with caution)

**Equipment:**
- Sterile syringes (1mL, 3mL, 5mL)
- Sterile needles (18G for drawing, 22-25G for injection)
- Alcohol prep pads (70% isopropyl alcohol)
- Sharps disposal container
- Refrigerated storage (2-8°C)
- Amber vials or aluminum foil (light protection)

**Optional but Recommended:**
- Laminar flow hood or biosafety cabinet
- Sterile gloves (nitrile, powder-free)
- Lab coat
- Safety glasses
- pH test strips (pH 5-8 optimal range)

## Sterile Technique Fundamentals

### Environmental Preparation:

**Before Starting:**
1. Clean work area with 70% isopropyl alcohol
2. Allow area to air dry completely
3. Gather all materials before beginning
4. Minimize air exposure time
5. Avoid working near open windows or HVAC vents

### Hand Hygiene Protocol:

1. Wash hands thoroughly with antimicrobial soap (30 seconds)
2. Dry with clean paper towel
3. Don sterile gloves
4. Avoid touching non-sterile surfaces
5. Change gloves if contamination suspected

### Aseptic Technique Steps:

**For Each Vial:**
1. Remove plastic cap from vial
2. Wipe rubber stopper with alcohol pad (circular motion)
3. Allow alcohol to evaporate (30 seconds)
4. Use new alcohol pad for bacteriostatic water vial
5. Draw solvent with sterile syringe
6. Expel air bubbles from syringe
7. Insert needle at 45-degree angle through stopper
8. Inject solvent slowly down vial wall

## Step-by-Step Reconstitution Protocol

### Universal Reconstitution Procedure:

**Phase 1: Preparation (5 minutes)**

Step 1: Remove peptide from refrigerator/freezer
Step 2: Allow to reach room temperature (15-20 minutes)
        - Prevents condensation inside vial
        - Ensures complete dissolution
Step 3: Inspect powder visually
        - Should be white to off-white
        - Dry and fluffy appearance
        - No discoloration or melting
Step 4: Calculate required volume for desired concentration
Step 5: Gather all materials on clean surface

**Phase 2: Solvent Addition (2 minutes)**

Step 1: Draw calculated volume of bacteriostatic water
Step 2: Expel air from syringe (hold upright, tap, press plunger)
Step 3: Wipe peptide vial stopper with alcohol (let dry 30 sec)
Step 4: Insert needle at 45-degree angle
Step 5: Inject solvent slowly down the WALL of the vial
        - CRITICAL: Do NOT spray directly onto powder
        - Direct spray can denature peptides
        - Aim for vial wall, let liquid run down
Step 6: Remove needle carefully
Step 7: Gently rotate vial (do NOT shake vigorously)

**Phase 3: Dissolution (5-10 minutes)**

Step 1: Place vial upright on clean surface
Step 2: Allow to sit undisturbed (3-5 minutes)
Step 3: Gently rotate every 1-2 minutes
Step 4: Continue until COMPLETELY clear
        - No visible particles
        - No cloudiness
        - No floating material
Step 5: If not fully dissolved after 10 minutes:
        - Gently swirl (avoid creating foam)
        - Let sit 5 more minutes
        - Do NOT shake vigorously

**Phase 4: Verification and Storage (2 minutes)**

Step 1: Inspect final solution:
        - Should be crystal clear
        - No particles or precipitate
        - No discoloration
Step 2: Label vial with:
        - Peptide name
        - Concentration (mg/mL)
        - Reconstitution date
        - Expiration date (30 days)
Step 3: Store immediately at 2-8°C (refrigerator)
Step 4: Protect from light (amber vial or foil wrap)
Step 5: Store upright, away from freezer section

## Concentration Calculations

### Basic Formula:

**Concentration (mg/mL) = Total Amount (mg) / Volume Added (mL)**

### Example Calculations:

**Example 1: BPC-157 (5mg vial)**
- Desired concentration: 2mg/mL
- Calculation: 5mg ÷ 2mg/mL = 2.5mL
- Action: Add 2.5mL bacteriostatic water
- Result: 2mg per 1mL

**Example 2: TB-500 (5mg vial)**
- Desired concentration: 2.5mg/mL
- Calculation: 5mg ÷ 2.5mg/mL = 2mL
- Action: Add 2mL bacteriostatic water
- Result: 2.5mg per 1mL

**Example 3: Semaglutide (5mg vial)**
- Desired concentration: 1.25mg/mL
- Calculation: 5mg ÷ 1.25mg/mL = 4mL
- Action: Add 4mL bacteriostatic water
- Result: 1.25mg per 1mL

### Concentration Table for Common Peptides:

| Peptide | Vial Size | Water Volume | Final Concentration |
|---------|-----------|--------------|---------------------|
| BPC-157 | 5mg | 2.5mL | 2mg/mL |
| TB-500 | 5mg | 2.0mL | 2.5mg/mL |
| Semaglutide | 5mg | 4.0mL | 1.25mg/mL |
| Tirzepatide | 10mg | 4.0mL | 2.5mg/mL |
| GHK-Cu | 50mg | 5.0mL | 10mg/mL |

## Peptide-Specific Reconstitution Notes

### BPC-157:
- Very water-soluble
- Standard bacteriostatic water works perfectly
- No special considerations
- Stable in solution 30-60 days refrigerated

### TB-500 (Thymosin Beta-4):
- Highly water-soluble
- Very stable peptide
- Can use lower water volumes
- Maintains activity up to 60 days refrigerated

### Semaglutide:
- GLP-1 analog, moderately soluble
- Use more water for lower concentration
- Light-sensitive (protect from light)
- 30-day stability recommended

### Tirzepatide:
- Dual GLP-1/GIP agonist
- Similar to semaglutide
- Protect from light
- Refrigerate immediately
- Do NOT freeze

### GHK-Cu (Copper Peptide):
- Very soluble in water
- May have blue tint (normal - copper complex)
- Stable for extended periods
- Can use higher concentrations

## Storage Guidelines

### Unreconstituted Peptides:

**Optimal Storage:**
- Temperature: 2-8°C (refrigerator) preferred
- Room temperature (15-25°C) acceptable for most
- Freezer (-20°C) for very long-term storage
- Protect from light and moisture
- Keep in original packaging
- Shelf life: 24-36 months (check COA)

### Reconstituted Peptides:

**Mandatory Storage Requirements:**
- Temperature: 2-8°C (refrigerator) ONLY
- Never freeze reconstituted peptides
- Protect from light (amber vial or foil)
- Store upright
- Away from freezer compartment
- Shelf life: 30 days maximum

**Signs of Degradation:**
- Cloudiness or turbidity
- Color change (yellowing, browning)
- Visible particles or precipitate
- Loss of clarity
- Unusual odor

**If ANY of these occur: DISCARD immediately**

## Troubleshooting Common Issues

### Problem: Peptide Won't Dissolve

**Possible Causes:**
- Incorrect solvent pH
- Insufficient mixing time
- Too little water added
- Peptide aggregation

**Solutions:**
1. Let sit 10-15 minutes at room temperature
2. Gently rotate vial every few minutes
3. Try warm water bath (37°C max, 5-10 minutes)
4. Consider adding more water
5. For persistent issues: add 1-2 drops of acetic acid

### Problem: Solution is Cloudy

**Possible Causes:**
- Incomplete dissolution
- Protein aggregation
- Bacterial contamination
- Expired peptide

**Solutions:**
- If immediately after mixing: let sit longer
- If persists after 20 minutes: discard and start over
- If develops cloudiness after storage: discard (contamination)
- Never use cloudy solutions

### Problem: Solution Changed Color

**Causes:**
- Peptide degradation
- Oxidation
- Bacterial growth
- Improper storage

**Action:** DISCARD - do NOT use

### Problem: Foam Formation During Mixing

**Causes:**
- Too vigorous shaking
- Rapid solvent addition
- Protein denaturation

**Prevention:**
- Inject water slowly down vial wall
- Gently rotate instead of shaking
- Allow bubbles to settle before continuing

**If foam occurs:**
- Stop mixing immediately
- Let sit 10 minutes for foam to dissipate
- Gently tilt vial (don't shake) to help foam collapse

## Advanced Techniques

### Using pH-Adjusted Solutions:

**For Poorly Soluble Peptides:**
1. Prepare 0.1M acetic acid solution
2. Use 10-20% acetic acid, 80-90% bacteriostatic water
3. Mix solvents first, then add to peptide
4. Target pH 4-6 for most peptides
5. Verify pH with test strips

### Aliquoting for Extended Stability:

**Protocol for Multi-Month Storage:**

1. Reconstitute entire vial with bacteriostatic water
2. Draw solution into multiple sterile syringes
3. Expel air completely from each syringe
4. Cap syringes with sterile needle caps
5. Freeze individual syringes at -20°C
6. Thaw one syringe as needed
7. Do NOT refreeze thawed aliquots

**Benefits:**
- Reduces freeze-thaw cycles
- Minimizes contamination risk
- Extends overall usability
- Maintains sterility

### Multiple Vial Reconstitution:

**For Consistent Concentrations:**
1. Calculate total water needed for all vials
2. Measure once, divide into equal portions
3. Reconstitute all vials simultaneously
4. Label each vial identically
5. Verify concentration consistency

## Quality Control and Documentation

### Research Documentation:

**Record for Each Batch:**
- Peptide name and batch number
- Reconstitution date and time
- Solvent type and volume
- Final concentration
- Storage location
- First use date
- Expiration date
- Observed appearance
- Any issues or deviations

### Validation Testing:

**Recommended QC Measures:**
- pH testing (5-8 optimal)
- Visual clarity inspection
- Sterility verification (if critical)
- Concentration verification (if equipment available)

## Safety and Disposal

### Personal Safety:

**Always Use:**
- Gloves (nitrile recommended)
- Lab coat or protective clothing
- Safety glasses
- Work in well-ventilated area

**Never:**
- Consume or inject research peptides
- Work with bare hands
- Recap needles
- Reuse syringes

### Sharps Disposal:

**Proper Protocol:**
1. Use FDA-approved sharps container
2. Never overfill (fill to line only)
3. Seal when 3/4 full
4. Dispose according to local regulations
5. Never throw in regular trash

### Peptide Disposal:

**For Expired or Contaminated Peptides:**
- Do NOT pour down drain
- Place in sealed container
- Label as "Pharmaceutical Waste"
- Dispose through institutional waste management
- Follow local hazardous waste guidelines

## Regulatory and Compliance Considerations

**CRITICAL DISCLAIMER:**

All peptides discussed in this guide are intended strictly for laboratory research purposes only. They are NOT approved for human consumption, therapeutic use, veterinary applications, or any other non-research purpose.

**Institutional Requirements:**
- IRB or IACUC approval may be required
- Follow all institutional biosafety protocols
- Maintain proper documentation
- Store in locked, temperature-controlled facilities
- Restrict access to authorized personnel only

**Legal Compliance:**
- Verify peptide legality in your jurisdiction
- Maintain proper purchase documentation
- Follow all federal and state regulations
- Do not distribute to unlicensed parties

## Conclusion

Proper peptide reconstitution is both an art and a science. Mastering sterile technique, understanding solvent selection, maintaining proper storage conditions, and following systematic protocols ensures optimal peptide stability and experimental reproducibility.

Key Takeaways:
1. Always use sterile technique
2. Add solvent slowly down vial wall
3. Never shake vigorously
4. Refrigerate immediately after reconstitution
5. Protect from light
6. Use within 30 days
7. Document everything
8. When in doubt, discard and start fresh

**Red Helix Research provides comprehensive support for research laboratories, including high-purity peptides with verified third-party Certificates of Analysis. All products are for legitimate research use only.**

---

**Need Help?** Contact our research support team for peptide-specific reconstitution guidance and troubleshooting assistance.
    `
  },
  {
    id: 'tirzepatide-research-guide',
    title: 'Tirzepatide (TRZ) Research Guide',
    excerpt: 'Comprehensive guide on Tirzepatide, a dual GLP-1/GIP receptor agonist for metabolic and endocrine research. Includes molecular data, reconstitution protocols, and published study references.',
    date: '2026-02-01',
    readTime: '10 min read',
    icon: Flame,
    keywords: 'tirzepatide research, GLP-1 GIP agonist, dual incretin, metabolic peptide',
    content: `
# Tirzepatide (TRZ) Research Guide

## Overview

Tirzepatide is a synthetic dual-acting glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. It is the first approved dual incretin agonist and has demonstrated significant efficacy in metabolic research.

## Molecular Characteristics

**Classification:** Dual GLP-1/GIP Receptor Agonist
**Molecular Weight:** ~4,813.45 Da
**Amino Acid Length:** 39 amino acids (modified GIP analog)
**Half-Life:** ~5 days (~120 hours)
**CAS Number:** 2023788-19-2
**Modifications:** C20 fatty diacid moiety for albumin binding and extended half-life

## Mechanism of Action

### Dual Receptor Activation:
1. **GIP Receptor Agonism:** Full agonist activity at the GIP receptor, promoting insulin secretion and adipocyte lipid metabolism
2. **GLP-1 Receptor Agonism:** Partial agonist at the GLP-1 receptor, enhancing glucose-dependent insulin release and suppressing glucagon
3. **Synergistic Effect:** Dual pathway activation produces enhanced metabolic effects compared to single-receptor agonists

### Key Research Findings:
- SURPASS clinical trial series demonstrated superior efficacy to semaglutide in head-to-head trials
- Significant effects on body weight reduction in clinical studies
- Improved glycemic control with lower hypoglycemia risk
- Cardiovascular outcome data under investigation

## Reconstitution Protocol

**For 10mg Tirzepatide vial:**
- Add 4mL bacteriostatic water for 2.5mg/mL concentration
- Inject slowly down vial wall at 45-degree angle
- Gently rotate — do NOT shake
- Allow 5-10 minutes for complete dissolution
- Store at 2-8°C, protect from light
- Use within 30 days; do NOT freeze reconstituted solution

## Quality Standards
- HPLC purity ≥98%
- Mass spectrometry molecular weight confirmation
- Endotoxin testing: <10 EU/mg
- Third-party COA with batch-specific data

**DISCLAIMER:** Tirzepatide is for laboratory research use only. Not for human consumption.
    `
  },
  {
    id: 'retatrutide-research-guide',
    title: 'Retatrutide (RT) Triple Agonist Research Guide',
    excerpt: 'Research overview of Retatrutide, the first-in-class triple hormone receptor agonist targeting GLP-1, GIP, and glucagon receptors. Molecular data, mechanisms, and research applications.',
    date: '2026-02-02',
    readTime: '10 min read',
    icon: Flame,
    keywords: 'retatrutide research, triple agonist, GLP-1 GIP glucagon, metabolic peptide',
    content: `
# Retatrutide (RT) Triple Agonist Research Guide

## Overview

Retatrutide (LY3437943) is a first-in-class triple hormone receptor agonist that activates GLP-1, GIP, and glucagon receptors simultaneously. This novel mechanism makes it one of the most potent metabolic research peptides currently under investigation.

## Molecular Characteristics

**Classification:** Triple GLP-1/GIP/Glucagon Receptor Agonist
**Molecular Weight:** ~4,605 Da
**Amino Acid Length:** 39 amino acids
**Half-Life:** ~6 days
**Structure:** Modified GIP-based peptide with C20 fatty acid chain

## Triple Receptor Mechanism

1. **GLP-1 Receptor:** Enhances glucose-dependent insulin secretion, suppresses appetite
2. **GIP Receptor:** Promotes insulin release, modulates lipid metabolism in adipose tissue
3. **Glucagon Receptor:** Increases hepatic energy expenditure, promotes lipolysis, thermogenesis

### Why Triple Agonism Matters:
- Glucagon receptor activation adds energy expenditure that dual agonists lack
- Phase 2 trials showed up to 24.2% body weight reduction at 48 weeks
- Represents a new paradigm in metabolic peptide research

## Reconstitution Protocol

**For standard lyophilized vial:**
- Use bacteriostatic water as solvent
- Inject slowly down vial wall
- Gently swirl — do NOT shake
- Store reconstituted solution at 2-8°C
- Protect from light, use within 30 days

## Research Applications
- Metabolic syndrome and obesity research
- Hepatic steatosis (NASH/NAFLD) investigation
- Energy expenditure and thermogenesis studies
- Comparative studies vs dual agonists

**DISCLAIMER:** Retatrutide is for laboratory research use only. Not for human consumption.
    `
  },
  {
    id: 'cjc-1295-research-guide',
    title: 'CJC-1295 Research Guide',
    excerpt: 'Research overview of CJC-1295, a growth hormone releasing hormone (GHRH) analog. Includes molecular data, mechanism of action, reconstitution protocols, and research applications.',
    date: '2026-02-03',
    readTime: '9 min read',
    icon: Activity,
    keywords: 'CJC-1295 research, GHRH analog, growth hormone releasing, peptide research',
    content: `
# CJC-1295 Research Guide

## Overview

CJC-1295 is a synthetic analog of growth hormone releasing hormone (GHRH) with amino acid substitutions that provide resistance to enzymatic degradation. It is commonly studied for its ability to stimulate pulsatile growth hormone secretion.

## Molecular Characteristics

**Classification:** GHRH Analog (Modified GRF 1-29)
**Molecular Weight:** ~3,647.28 Da
**Amino Acid Length:** 30 amino acids
**Half-Life:** ~8 days (with DAC), ~30 minutes (without DAC)
**CAS Number:** 863288-34-0
**Variants:** CJC-1295 with DAC (Drug Affinity Complex) and CJC-1295 no DAC (also called Modified GRF 1-29)

## Mechanism of Action

1. **GHRH Receptor Binding:** Binds to GHRH receptors on anterior pituitary somatotroph cells
2. **Pulsatile GH Release:** Amplifies natural growth hormone release pulses without disrupting normal feedback
3. **IGF-1 Elevation:** Downstream increase in Insulin-like Growth Factor 1 production
4. **DAC Variant:** Drug Affinity Complex binds to serum albumin, extending half-life from minutes to days

## Reconstitution Protocol

**For 2mg or 5mg vial:**
- Add 1-2mL bacteriostatic water
- Inject slowly down vial wall
- Gently swirl until fully dissolved
- Store at 2-8°C, protect from light
- Use within 30 days

## Research Applications
- Growth hormone axis research
- Age-related GH decline studies
- Body composition research
- Synergistic protocols with GHRPs (e.g., Ipamorelin)

**DISCLAIMER:** CJC-1295 is for laboratory research use only. Not for human consumption.
    `
  },
  {
    id: 'ipamorelin-research-guide',
    title: 'Ipamorelin Research Guide',
    excerpt: 'Research guide on Ipamorelin, a selective growth hormone secretagogue receptor (GHSR) agonist. Molecular data, selectivity profile, and research protocols.',
    date: '2026-02-03',
    readTime: '9 min read',
    icon: Activity,
    keywords: 'ipamorelin research, growth hormone secretagogue, GHSR agonist, selective GH peptide',
    content: `
# Ipamorelin Research Guide

## Overview

Ipamorelin is a synthetic pentapeptide and selective growth hormone secretagogue receptor (GHS-R1a) agonist. It is notable for its high selectivity — it stimulates growth hormone release without significantly affecting cortisol, prolactin, or ACTH levels, making it one of the cleanest GH-releasing peptides.

## Molecular Characteristics

**Classification:** Selective GHS-R1a Agonist (Ghrelin Mimetic)
**Molecular Weight:** ~711.85 Da
**Amino Acid Sequence:** Aib-His-D-2-Nal-D-Phe-Lys-NH2 (5 amino acids)
**CAS Number:** 170851-70-4
**Half-Life:** ~2 hours
**Selectivity:** Highly selective for GH release; minimal effect on cortisol, prolactin, ACTH

## Mechanism of Action

1. **GHS-R1a Activation:** Mimics ghrelin at the growth hormone secretagogue receptor
2. **Pulsatile GH Release:** Stimulates GH pulses from the anterior pituitary
3. **Dose-Dependent Response:** Linear dose-response relationship in published studies
4. **Synergy with GHRH:** Often studied in combination with CJC-1295 for amplified GH release

## Reconstitution Protocol

**For 2mg or 5mg vial:**
- Add 1-2mL bacteriostatic water
- Inject slowly down vial wall
- Gently swirl until dissolved (typically 1-2 minutes)
- Store at 2-8°C
- Stable for 30 days refrigerated

## Research Applications
- Selective growth hormone release studies
- GH axis research without cortisol interference
- Body composition and metabolic research
- Combination protocols with GHRH analogs

**DISCLAIMER:** Ipamorelin is for laboratory research use only. Not for human consumption.
    `
  },
  {
    id: 'sermorelin-research-guide',
    title: 'Sermorelin Research Guide',
    excerpt: 'Research overview of Sermorelin, a GHRH analog consisting of the first 29 amino acids of endogenous GHRH. Molecular structure, research protocols, and applications.',
    date: '2026-02-04',
    readTime: '8 min read',
    icon: Activity,
    keywords: 'sermorelin research, GHRH 1-29, growth hormone releasing, sermorelin peptide',
    content: `
# Sermorelin Research Guide

## Overview

Sermorelin (GRF 1-29 NH2) is a synthetic peptide analog consisting of the first 29 amino acids of the naturally occurring 44-amino acid human growth hormone releasing hormone (GHRH). It retains full biological activity of the parent molecule and has been extensively studied since the 1980s.

## Molecular Characteristics

**Classification:** GHRH Analog (GRF 1-29)
**Molecular Weight:** ~3,357.93 Da
**Amino Acid Length:** 29 amino acids
**CAS Number:** 86168-78-7
**Half-Life:** ~10-20 minutes
**Solubility:** Water-soluble

## Mechanism of Action

1. **GHRH Receptor Binding:** Directly activates GHRH receptors on pituitary somatotrophs
2. **Physiological GH Release:** Stimulates growth hormone in a natural pulsatile pattern
3. **Preserved Feedback:** Does not override negative feedback mechanisms, maintaining safety profile
4. **IGF-1 Stimulation:** Downstream elevation of IGF-1 levels

## Reconstitution and Storage

- Add 1-2mL bacteriostatic water per vial
- Inject slowly, swirl gently
- Refrigerate at 2-8°C immediately
- Use within 14-21 days (shorter half-life peptide)

**DISCLAIMER:** Sermorelin is for laboratory research use only. Not for human consumption.
    `
  },
  {
    id: 'tesamorelin-research-guide',
    title: 'Tesamorelin Research Guide',
    excerpt: 'Research guide on Tesamorelin, an FDA-recognized GHRH analog studied for growth hormone stimulation and lipodystrophy research. Molecular data and protocols.',
    date: '2026-02-04',
    readTime: '8 min read',
    icon: Activity,
    keywords: 'tesamorelin research, GHRH analog, lipodystrophy peptide, growth hormone',
    content: `
# Tesamorelin Research Guide

## Overview

Tesamorelin is a synthetic GHRH analog with a trans-3-hexenoic acid modification at the N-terminus that enhances stability over native GHRH. It is the only GHRH analog that received FDA approval (for HIV-associated lipodystrophy), making it one of the most clinically validated peptides in this class.

## Molecular Characteristics

**Classification:** Modified GHRH Analog
**Molecular Weight:** ~5,135.87 Da
**Amino Acid Length:** 44 amino acids (full GHRH length + modification)
**CAS Number:** 218949-48-5
**Modification:** Trans-3-hexenoic acid at N-terminus
**Half-Life:** ~26 minutes

## Research Applications

- Growth hormone axis stimulation studies
- Visceral adiposity and lipodystrophy research
- Cognitive function preservation studies (emerging research in mild cognitive impairment)
- Hepatic fat reduction research

## Reconstitution Protocol

- Add 2mL bacteriostatic water per vial
- Inject slowly, gently swirl
- Refrigerate at 2-8°C
- Use within 21-30 days

**DISCLAIMER:** Tesamorelin is for laboratory research use only. Not for human consumption.
    `
  },
  {
    id: 'ghk-cu-research-guide',
    title: 'GHK-Cu (Copper Peptide) Research Guide',
    excerpt: 'Research overview of GHK-Cu, a naturally occurring copper-binding tripeptide studied for tissue remodeling, collagen synthesis, and wound healing mechanisms.',
    date: '2026-02-05',
    readTime: '9 min read',
    icon: Shield,
    keywords: 'GHK-Cu research, copper peptide, collagen synthesis, tissue remodeling peptide',
    content: `
# GHK-Cu (Copper Peptide) Research Guide

## Overview

GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring tripeptide-copper complex found in human plasma, saliva, and urine. It was first identified by Dr. Loren Pickart in the 1970s. GHK-Cu levels decline with age, and research suggests it plays roles in tissue remodeling, wound healing, and gene expression modulation.

## Molecular Characteristics

**Full Name:** Glycyl-L-Histidyl-L-Lysine Copper(II) Complex
**Molecular Formula:** C₁₄H₂₃CuN₆O₄
**Molecular Weight:** ~403.92 Da (with copper)
**Amino Acid Sequence:** Gly-His-Lys (tripeptide)
**CAS Number:** 49557-75-7
**Copper Binding:** Strong affinity for Cu²⁺ ions
**Appearance:** May have slight blue tint (normal — copper complex)

## Mechanism of Action

1. **Copper Delivery:** Serves as a bioavailable copper transport molecule
2. **Gene Expression:** Research shows modulation of ~4,000+ genes (Pickart et al.), many involved in tissue repair
3. **Collagen Stimulation:** Promotes collagen I, III, and elastin synthesis
4. **Anti-Inflammatory:** Reduces pro-inflammatory cytokines (TNF-α, IL-6)
5. **Antioxidant Activity:** Superoxide dismutase support via copper delivery

## Reconstitution Protocol

**For 50mg or 100mg vial:**
- Add 2-5mL bacteriostatic water
- Dissolves rapidly — very water-soluble
- Solution may appear slightly blue (normal)
- Store at 2-8°C, stable for 30-60 days
- Higher concentrations (10mg/mL) are feasible

**DISCLAIMER:** GHK-Cu is for laboratory research use only. Not for human consumption.
    `
  },
  {
    id: 'pt-141-research-guide',
    title: 'PT-141 (Bremelanotide) Research Guide',
    excerpt: 'Research guide on PT-141 (Bremelanotide), a melanocortin receptor agonist studied for its unique central nervous system mechanism of action in sexual function research.',
    date: '2026-02-05',
    readTime: '8 min read',
    icon: Heart,
    keywords: 'PT-141 research, bremelanotide, melanocortin agonist, MC4R peptide',
    content: `
# PT-141 (Bremelanotide) Research Guide

## Overview

PT-141 (Bremelanotide) is a synthetic cyclic heptapeptide melanocortin receptor agonist. Unlike PDE5 inhibitors that act on the vascular system, PT-141 acts through the central nervous system via melanocortin-4 receptor (MC4R) activation. It received FDA approval as Vyleesi in 2019 for hypoactive sexual desire disorder.

## Molecular Characteristics

**Classification:** Melanocortin-4 Receptor (MC4R) Agonist
**Molecular Weight:** ~1,025.18 Da
**Structure:** Cyclic heptapeptide (7 amino acids)
**Sequence:** Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH
**CAS Number:** 189691-06-3
**Half-Life:** ~2.7 hours
**Origin:** Derived from Melanotan II with metabolite optimization

## Mechanism of Action

1. **MC4R Activation:** Activates melanocortin-4 receptors in the hypothalamus
2. **Central Mechanism:** Acts on the CNS rather than peripheral vasculature
3. **Dopaminergic Effects:** Downstream modulation of dopamine pathways

## Reconstitution Protocol

- Add 1-2mL bacteriostatic water per vial
- Dissolves readily in water
- Store at 2-8°C, use within 30 days

**DISCLAIMER:** PT-141 is for laboratory research use only. Not for human consumption.
    `
  },
  {
    id: 'selank-research-guide',
    title: 'Selank Research Guide',
    excerpt: 'Research overview of Selank, a synthetic analog of tuftsin with anxiolytic and nootropic properties. Molecular data, mechanism of action, and cognitive research applications.',
    date: '2026-02-06',
    readTime: '8 min read',
    icon: Brain,
    keywords: 'selank research, tuftsin analog, anxiolytic peptide, nootropic research',
    content: `
# Selank Research Guide

## Overview

Selank (TP-7) is a synthetic heptapeptide analog of the naturally occurring immunomodulatory peptide tuftsin (Thr-Lys-Pro-Arg) with an added Pro-Gly-Pro sequence. Developed at the Institute of Molecular Genetics of the Russian Academy of Sciences, Selank is studied for its anxiolytic, nootropic, and immunomodulatory properties.

## Molecular Characteristics

**Classification:** Tuftsin Analog / Anxiolytic-Nootropic Peptide
**Molecular Weight:** ~751.87 Da
**Amino Acid Sequence:** Thr-Lys-Pro-Arg-Pro-Gly-Pro (7 amino acids)
**CAS Number:** 129954-34-3
**Half-Life:** Several minutes (intranasal administration extends effective duration)
**Stability:** Stable synthetic peptide

## Mechanism of Action

1. **GABA Modulation:** Influences GABAergic neurotransmission without direct receptor binding
2. **BDNF Expression:** Increases brain-derived neurotrophic factor expression
3. **Enkephalin Modulation:** Affects endogenous enkephalin metabolism
4. **Serotonin Metabolism:** Modulates serotonin and dopamine turnover
5. **IL-6 Modulation:** Immunomodulatory effects through cytokine regulation

## Research Applications
- Anxiety and stress resilience research
- Cognitive enhancement and memory studies
- Immune function modulation
- Neuroprotection research

## Reconstitution
- Dissolve in bacteriostatic water or sterile saline
- Store at 2-8°C
- Typically studied via intranasal administration in research models

**DISCLAIMER:** Selank is for laboratory research use only. Not for human consumption.
    `
  },
  {
    id: 'semax-research-guide',
    title: 'Semax Research Guide',
    excerpt: 'Research guide on Semax, a synthetic ACTH analog peptide studied for cognitive enhancement, neuroprotection, and neuroplasticity mechanisms.',
    date: '2026-02-06',
    readTime: '8 min read',
    icon: Brain,
    keywords: 'semax research, ACTH analog, nootropic peptide, neuroprotection',
    content: `
# Semax Research Guide

## Overview

Semax is a synthetic heptapeptide analog of the adrenocorticotropic hormone (ACTH) fragment 4-10, with an added Pro-Gly-Pro C-terminal tripeptide for stability. Developed at the Institute of Molecular Genetics in Russia, it has been studied extensively for cognitive enhancement and neuroprotective properties.

## Molecular Characteristics

**Classification:** ACTH(4-10) Analog / Nootropic Peptide
**Molecular Weight:** ~813.93 Da
**Amino Acid Sequence:** Met-Glu-His-Phe-Pro-Gly-Pro (7 amino acids)
**CAS Number:** 80714-61-0
**Half-Life:** Short (minutes), though effects persist longer
**Key Feature:** Retains neurotropic activity of ACTH without hormonal/steroidogenic effects

## Mechanism of Action

1. **BDNF Upregulation:** Significant increase in brain-derived neurotrophic factor
2. **NGF Modulation:** Affects nerve growth factor expression
3. **Dopamine/Serotonin Systems:** Modulates monoamine neurotransmitter turnover
4. **No Hormonal Activity:** Unlike ACTH, does not stimulate adrenal cortisol production
5. **Neuroplasticity:** Promotes dendritic branching and synaptic formation

## Research Applications
- Cognitive enhancement and attention studies
- Stroke recovery and neuroprotection research
- Neurodegenerative disease research
- BDNF-mediated neuroplasticity studies

**DISCLAIMER:** Semax is for laboratory research use only. Not for human consumption.
    `
  },
  {
    id: 'pinealon-research-guide',
    title: 'Pinealon Research Guide',
    excerpt: 'Research overview of Pinealon, a brain-specific tripeptide studied for neuroprotection and cognitive function. Part of the Khavinson peptide bioregulator family.',
    date: '2026-02-07',
    readTime: '7 min read',
    icon: Brain,
    keywords: 'pinealon research, brain peptide, neuroprotective tripeptide, Khavinson peptide',
    content: `
# Pinealon Research Guide

## Overview

Pinealon (EDR) is a synthetic tripeptide (Glu-Asp-Arg) studied as a brain-specific peptide bioregulator. It belongs to the family of short peptides researched by Professor Vladimir Khavinson at the Saint Petersburg Institute of Bioregulation and Gerontology. Research suggests it may have neuroprotective and gene-regulatory properties.

## Molecular Characteristics

**Classification:** Brain-Specific Peptide Bioregulator
**Molecular Weight:** ~418.40 Da
**Amino Acid Sequence:** Glu-Asp-Arg (3 amino acids)
**Structure:** Linear tripeptide
**Solubility:** Water-soluble

## Mechanism of Action (Research Findings)

1. **Gene Expression:** Research suggests modulation of genes involved in neuronal function
2. **Antioxidant Effects:** May reduce oxidative stress markers in neural tissue
3. **Cell Proliferation:** Studies indicate potential stimulation of neural cell proliferation
4. **Pineal Gland:** Named for its purported affinity for pineal gland tissue

## Research Applications
- Neuroprotection and cognitive aging research
- Peptide bioregulation studies
- Oxidative stress in neural tissue
- Short peptide gene modulation research

**DISCLAIMER:** Pinealon is for laboratory research use only. Not for human consumption.
    `
  },
  {
    id: 'epithalon-research-guide',
    title: 'Epithalon Research Guide',
    excerpt: 'Research guide on Epithalon (Epitalon), a tetrapeptide studied for its effects on telomerase activation, circadian rhythm, and aging research.',
    date: '2026-02-07',
    readTime: '9 min read',
    icon: Dna,
    keywords: 'epithalon research, epitalon, telomerase peptide, anti-aging research',
    content: `
# Epithalon (Epitalon) Research Guide

## Overview

Epithalon (also spelled Epitalon) is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) based on the naturally occurring peptide Epithalamin, which is produced by the pineal gland. Research by Professor Vladimir Khavinson and colleagues has focused on its potential effects on telomerase activity, circadian rhythm regulation, and biomarkers of aging.

## Molecular Characteristics

**Classification:** Pineal Peptide / Telomerase Research Peptide
**Molecular Weight:** ~390.35 Da
**Amino Acid Sequence:** Ala-Glu-Asp-Gly (4 amino acids)
**CAS Number:** 307297-39-8
**Solubility:** Water-soluble
**Stability:** Stable as lyophilized powder

## Mechanism of Action (Research Findings)

1. **Telomerase Activation:** Published studies suggest Epithalon activates telomerase in human somatic cells (Khavinson et al., 2003)
2. **Melatonin Regulation:** Research indicates modulation of pineal gland melatonin production
3. **Circadian Rhythm:** May help normalize disrupted circadian patterns in aging models
4. **Antioxidant Gene Expression:** Studies suggest upregulation of antioxidant enzyme genes

## Reconstitution Protocol
- Add 1-2mL bacteriostatic water
- Dissolves easily — very water-soluble
- Store at 2-8°C
- Stable for 30+ days refrigerated

## Research Applications
- Telomere biology and aging research
- Circadian rhythm studies
- Pineal gland function research
- Biomarkers of cellular aging

**DISCLAIMER:** Epithalon is for laboratory research use only. Not for human consumption.
    `
  },
  {
    id: 'mots-c-research-guide',
    title: 'MOTS-c Research Guide',
    excerpt: 'Research overview of MOTS-c, a mitochondrial-derived peptide studied for metabolic regulation, exercise mimetic effects, and cellular energy metabolism.',
    date: '2026-02-08',
    readTime: '9 min read',
    icon: Zap,
    keywords: 'MOTS-c research, mitochondrial peptide, metabolic regulation, exercise mimetic',
    content: `
# MOTS-c Research Guide

## Overview

MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA Type-c) is a mitochondrial-derived peptide (MDP) discovered in 2015 by Dr. Changhan Lee's lab at USC. It is encoded within the mitochondrial genome and is one of the first identified mitochondrial-encoded signaling peptides that regulate nuclear gene expression — a form of retrograde signaling.

## Molecular Characteristics

**Classification:** Mitochondrial-Derived Peptide (MDP)
**Molecular Weight:** ~2,174.67 Da
**Amino Acid Length:** 16 amino acids
**Sequence:** MRWQEMGYIFYPRKLR
**Encoded By:** Mitochondrial 12S rRNA gene
**CAS Number:** 1627580-64-6

## Mechanism of Action

1. **AMPK Activation:** Activates AMP-activated protein kinase, a master metabolic regulator
2. **Folate-Methionine Cycle:** Regulates one-carbon metabolism and de novo purine biosynthesis
3. **Nuclear Translocation:** Under metabolic stress, MOTS-c translocates to the nucleus and regulates gene expression
4. **Insulin Sensitivity:** Enhances glucose uptake and insulin sensitivity in skeletal muscle
5. **Exercise Mimetic:** Mimics some metabolic effects of physical exercise

## Research Applications
- Metabolic syndrome and insulin resistance research
- Exercise physiology and mimetic studies
- Mitochondrial biology and retrograde signaling
- Aging and cellular energy metabolism
- Obesity and metabolic disease research

## Reconstitution
- Add 1-2mL bacteriostatic water
- Store at 2-8°C, use within 30 days
- Protect from light

**DISCLAIMER:** MOTS-c is for laboratory research use only. Not for human consumption.
    `
  },
  {
    id: 'melanotan-2-research-guide',
    title: 'Melanotan II (MT-2) Research Guide',
    excerpt: 'Research guide on Melanotan II, a synthetic melanocortin receptor agonist studied for melanogenesis, photoprotection, and melanocortin pathway research.',
    date: '2026-02-08',
    readTime: '8 min read',
    icon: Sun,
    keywords: 'melanotan 2 research, MT-2, melanocortin agonist, melanogenesis peptide',
    content: `
# Melanotan II (MT-2) Research Guide

## Overview

Melanotan II (MT-2) is a synthetic cyclic heptapeptide analog of alpha-melanocyte-stimulating hormone (α-MSH). Originally developed at the University of Arizona, it is a non-selective melanocortin receptor agonist that activates MC1R through MC5R. It is primarily studied for melanogenesis and melanocortin pathway research.

## Molecular Characteristics

**Classification:** Non-Selective Melanocortin Receptor Agonist
**Molecular Weight:** ~1,024.18 Da
**Structure:** Cyclic heptapeptide
**Sequence:** Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2
**CAS Number:** 121062-08-6
**Half-Life:** ~1-2 hours

## Mechanism of Action

1. **MC1R Activation:** Stimulates melanocytes to produce melanin (melanogenesis)
2. **Non-Selective Binding:** Activates multiple melanocortin receptor subtypes (MC1R-MC5R)
3. **cAMP Pathway:** MC1R activation increases intracellular cAMP, triggering tyrosinase and melanin production

## Research Applications
- Melanogenesis and pigmentation research
- UV photoprotection studies
- Melanocortin receptor signaling pathways
- Comparison studies with selective agonists (MT-1/Afamelanotide)

**DISCLAIMER:** Melanotan II is for laboratory research use only. Not for human consumption.
    `
  },
  {
    id: 'melanotan-1-research-guide',
    title: 'Melanotan I (Afamelanotide) Research Guide',
    excerpt: 'Research overview of Melanotan I (Afamelanotide), a linear α-MSH analog with selective MC1R activity studied for photoprotection and melanogenesis.',
    date: '2026-02-09',
    readTime: '7 min read',
    icon: Sun,
    keywords: 'melanotan 1 research, afamelanotide, MC1R agonist, photoprotection peptide',
    content: `
# Melanotan I (Afamelanotide) Research Guide

## Overview

Melanotan I (also known as Afamelanotide) is a synthetic linear tridecapeptide analog of α-melanocyte-stimulating hormone (α-MSH). Unlike the non-selective Melanotan II, Afamelanotide is more selective for the MC1R receptor. It received EMA approval under the brand name Scenesse for erythropoietic protoporphyria (EPP).

## Molecular Characteristics

**Classification:** MC1R-Preferring Melanocortin Agonist
**Molecular Weight:** ~1,646.85 Da
**Amino Acid Length:** 13 amino acids (linear peptide)
**CAS Number:** 75921-69-6
**Half-Life:** ~30 minutes
**Key Difference from MT-2:** Linear structure, more selective, no cyclic ring

## Mechanism of Action

1. **Selective MC1R Activation:** Preferential activation of melanocortin-1 receptor on melanocytes
2. **Eumelanin Production:** Stimulates production of photoprotective eumelanin (brown/black melanin)
3. **Fewer Off-Target Effects:** More selective than MT-2, reducing non-melanogenic effects

**DISCLAIMER:** Melanotan I is for laboratory research use only (except under approved clinical use as Scenesse). Research-grade peptides are not for human consumption.
    `
  },
  {
    id: 'kisspeptin-research-guide',
    title: 'Kisspeptin Research Guide',
    excerpt: 'Research guide on Kisspeptin, a neuropeptide critical for GnRH signaling, reproductive endocrinology, and puberty onset research.',
    date: '2026-02-09',
    readTime: '8 min read',
    icon: Heart,
    keywords: 'kisspeptin research, GnRH signaling, reproductive peptide, KISS1',
    content: `
# Kisspeptin Research Guide

## Overview

Kisspeptin refers to a family of peptides encoded by the KISS1 gene. The full-length kisspeptin-54 and its shorter fragments (kisspeptin-14, -13, -10) act on the kisspeptin receptor (KISS1R/GPR54) and are critical upstream regulators of GnRH (gonadotropin-releasing hormone) neurons. Kisspeptin is considered the master regulator of reproductive hormone signaling.

## Molecular Characteristics

**Classification:** GnRH Upstream Regulator / Reproductive Neuropeptide
**Gene:** KISS1
**Primary Form:** Kisspeptin-54 (54 amino acids)
**Active Fragments:** Kisspeptin-10, -13, -14
**Receptor:** KISS1R (GPR54)
**CAS Number (Kisspeptin-10):** 374675-21-5

## Mechanism of Action

1. **GnRH Stimulation:** Directly activates GnRH neurons in the hypothalamus
2. **LH/FSH Release:** Downstream stimulation of luteinizing hormone and follicle-stimulating hormone
3. **Puberty Regulation:** Loss-of-function mutations in KISS1R cause hypogonadotropic hypogonadism
4. **Reproductive Axis Master Switch:** Central gatekeeper for reproductive maturation

## Research Applications
- Reproductive endocrinology research
- Puberty onset and timing studies
- Fertility and IVF research
- Hypothalamic-pituitary-gonadal axis research

**DISCLAIMER:** Kisspeptin is for laboratory research use only. Not for human consumption.
    `
  },
  {
    id: 'thymosin-alpha-1-research-guide',
    title: 'Thymosin Alpha-1 Research Guide',
    excerpt: 'Research overview of Thymosin Alpha-1, an immune-modulating peptide derived from the thymus gland. FDA orphan drug with extensive immunological research.',
    date: '2026-02-10',
    readTime: '9 min read',
    icon: Shield,
    keywords: 'thymosin alpha-1 research, immune peptide, thymus peptide, immunomodulation',
    content: `
# Thymosin Alpha-1 Research Guide

## Overview

Thymosin Alpha-1 (Tα1) is a naturally occurring peptide originally isolated from thymic tissue (Thymosin Fraction 5) by Allan Goldstein in the 1970s. It is a 28-amino acid peptide that plays a central role in adaptive immune function. It is approved in over 35 countries as Zadaxin for hepatitis B and C treatment and as an immune adjuvant.

## Molecular Characteristics

**Classification:** Thymic Immunomodulatory Peptide
**Molecular Weight:** ~3,108 Da
**Amino Acid Length:** 28 amino acids
**CAS Number:** 62304-98-7
**N-Terminal:** Acetylated (Ac-Ser)
**Solubility:** Water-soluble

## Mechanism of Action

1. **T-Cell Maturation:** Promotes differentiation and maturation of T-lymphocytes
2. **Dendritic Cell Activation:** Enhances dendritic cell function and antigen presentation
3. **TLR Signaling:** Activates Toll-like receptors (TLR2, TLR9), bridging innate and adaptive immunity
4. **NK Cell Enhancement:** Increases natural killer cell cytotoxicity
5. **Cytokine Modulation:** Balances Th1/Th2 immune response

## Research Applications
- Immune function and immunodeficiency research
- Vaccine adjuvant studies
- Hepatitis and viral infection research
- Cancer immunology and immune checkpoint studies
- Sepsis and critical care immunomodulation

**DISCLAIMER:** Thymosin Alpha-1 is for laboratory research use only. Not for human consumption outside of approved clinical formulations.
    `
  },
  {
    id: 'ss-31-research-guide',
    title: 'SS-31 (Elamipretide) Research Guide',
    excerpt: 'Research guide on SS-31 (Elamipretide), a mitochondrial-targeting tetrapeptide studied for cardiolipin binding, electron transport optimization, and mitochondrial disease.',
    date: '2026-02-10',
    readTime: '9 min read',
    icon: Zap,
    keywords: 'SS-31 research, elamipretide, mitochondrial peptide, cardiolipin binding',
    content: `
# SS-31 (Elamipretide) Research Guide

## Overview

SS-31 (also known as Elamipretide or Bendavia) is a synthetic cell-permeable tetrapeptide that selectively targets the inner mitochondrial membrane. Developed by Dr. Hazel Szeto and colleagues, it binds to cardiolipin, a phospholipid essential for electron transport chain function, and has been studied in clinical trials for mitochondrial diseases.

## Molecular Characteristics

**Classification:** Mitochondria-Targeting Peptide (Szeto-Schiller Peptide)
**Molecular Weight:** ~640.77 Da
**Amino Acid Sequence:** D-Arg-Dmt-Lys-Phe-NH2 (4 amino acids)
**CAS Number:** 736992-21-5
**Key Feature:** Cell-permeable, concentrates 1000-5000x in mitochondria
**Charge:** Cationic (+3 at physiological pH)

## Mechanism of Action

1. **Cardiolipin Binding:** Selectively binds cardiolipin in the inner mitochondrial membrane
2. **ETC Optimization:** Stabilizes electron transport chain complexes, reducing electron leak
3. **ROS Reduction:** Decreases mitochondrial reactive oxygen species production
4. **ATP Restoration:** Restores ATP production in dysfunctional mitochondria
5. **Membrane Potential:** Preserves mitochondrial membrane potential under stress

## Research Applications
- Mitochondrial disease research
- Cardiac ischemia-reperfusion injury studies
- Aging and mitochondrial dysfunction
- Kidney disease and organ transplant research
- Neurodegenerative disease (mitochondrial component)

**DISCLAIMER:** SS-31 is for laboratory research use only. Not for human consumption.
    `
  },
  {
    id: 'igf1-lr3-research-guide',
    title: 'IGF-1 LR3 Research Guide',
    excerpt: 'Research overview of IGF-1 LR3, a modified insulin-like growth factor with extended half-life. Molecular data, mechanism, and growth factor research applications.',
    date: '2026-02-11',
    readTime: '9 min read',
    icon: Dna,
    keywords: 'IGF-1 LR3 research, insulin-like growth factor, long R3, growth peptide',
    content: `
# IGF-1 LR3 Research Guide

## Overview

IGF-1 LR3 (Long R3 Insulin-like Growth Factor-1) is a modified version of human IGF-1 with an arginine substitution at position 3 and a 13-amino acid N-terminal extension. These modifications significantly reduce binding to IGF binding proteins (IGFBPs), resulting in a much longer half-life and enhanced bioactivity compared to native IGF-1.

## Molecular Characteristics

**Classification:** Modified Insulin-like Growth Factor
**Molecular Weight:** ~9,111 Da
**Amino Acid Length:** 83 amino acids (70 native + 13 extension)
**Modifications:** Glu3→Arg3 substitution + 13-AA N-terminal extension
**CAS Number:** 946870-92-4
**Half-Life:** ~20-30 hours (vs ~15 minutes for native IGF-1)
**Key Feature:** Reduced IGFBP binding = higher free bioactive concentration

## Mechanism of Action

1. **IGF-1R Activation:** Binds to the IGF-1 receptor with full agonist activity
2. **Reduced IGFBP Binding:** Modifications prevent sequestration by binding proteins
3. **PI3K/Akt Pathway:** Activates phosphoinositide 3-kinase and Akt signaling
4. **Cell Proliferation:** Potent stimulator of cell growth and differentiation
5. **Anti-Apoptotic:** Promotes cell survival via Akt-mediated pathways

## Research Applications
- Growth factor signaling research
- Muscle cell proliferation and differentiation studies
- Cancer biology (IGF axis dysregulation)
- Metabolic research and glucose homeostasis

## Reconstitution
- Add 0.1M acetic acid or bacteriostatic water
- Handle carefully — sensitive to pH extremes
- Store at -20°C for long-term, 2-8°C for short-term use

**DISCLAIMER:** IGF-1 LR3 is for laboratory research use only. Not for human consumption.
    `
  },
  {
    id: 'hgh-fragment-176-191-research-guide',
    title: 'HGH Fragment 176-191 Research Guide',
    excerpt: 'Research guide on HGH Fragment 176-191 (AOD-9604), the lipolytic fragment of human growth hormone. Mechanism, fat metabolism research, and protocols.',
    date: '2026-02-11',
    readTime: '8 min read',
    icon: Flame,
    keywords: 'HGH fragment research, AOD-9604, growth hormone fragment, lipolytic peptide',
    content: `
# HGH Fragment 176-191 Research Guide

## Overview

HGH Fragment 176-191 (also known as AOD-9604) is a modified peptide fragment corresponding to amino acids 176-191 of the human growth hormone molecule. This specific fragment retains the lipolytic (fat-burning) activity of GH while having no effect on growth or insulin resistance. Research was pioneered at Monash University in Australia.

## Molecular Characteristics

**Classification:** Growth Hormone Fragment / Lipolytic Peptide
**Molecular Weight:** ~1,817.12 Da
**Amino Acid Length:** 16 amino acids (positions 176-191 of hGH)
**CAS Number:** 221231-10-3
**Modifications:** C-terminal tyrosine added for stability
**Key Feature:** Isolates fat metabolism effects from GH's growth/diabetogenic effects

## Mechanism of Action

1. **Lipolysis Stimulation:** Activates beta-3 adrenergic receptor-mediated fat breakdown
2. **Anti-Lipogenic:** Inhibits lipogenesis (new fat formation)
3. **No IGF-1 Elevation:** Does not stimulate IGF-1 or promote growth
4. **No Insulin Resistance:** Unlike full GH, does not impair glucose tolerance

## Research Applications
- Fat metabolism and lipolysis research
- Obesity and metabolic syndrome studies
- Growth hormone fragment biology
- Selective GH activity research

**DISCLAIMER:** HGH Fragment 176-191 is for laboratory research use only. Not for human consumption.
    `
  },
  {
    id: 'll-37-research-guide',
    title: 'LL-37 Antimicrobial Peptide Research Guide',
    excerpt: 'Research overview of LL-37 (Cathelicidin), the only human cathelicidin antimicrobial peptide. Innate immunity, wound healing, and antimicrobial research.',
    date: '2026-02-12',
    readTime: '9 min read',
    icon: Shield,
    keywords: 'LL-37 research, cathelicidin, antimicrobial peptide, innate immunity',
    content: `
# LL-37 Antimicrobial Peptide Research Guide

## Overview

LL-37 is the only cathelicidin antimicrobial peptide (CAMP) found in humans. It is a 37-amino acid peptide cleaved from the C-terminus of the precursor protein hCAP18 by proteinase 3. LL-37 is expressed by neutrophils, macrophages, epithelial cells, and other immune cells, and serves as a critical component of the innate immune system.

## Molecular Characteristics

**Classification:** Human Cathelicidin Antimicrobial Peptide
**Molecular Weight:** ~4,493.33 Da
**Amino Acid Length:** 37 amino acids
**Sequence Start:** LLGDFFRKSKEKIGKEFKR...
**CAS Number:** 154947-66-7
**Structure:** Alpha-helical in membrane environments
**Charge:** +6 at physiological pH (cationic)
**Precursor:** hCAP18 (human cationic antimicrobial protein, 18 kDa)

## Mechanism of Action

1. **Membrane Disruption:** Inserts into bacterial membranes, forming pores
2. **Broad-Spectrum Activity:** Active against gram-positive, gram-negative bacteria, fungi, and enveloped viruses
3. **Immunomodulation:** Recruits immune cells, modulates TLR signaling
4. **Wound Healing:** Promotes re-epithelialization and angiogenesis
5. **Biofilm Disruption:** Inhibits and disrupts bacterial biofilm formation

## Research Applications
- Antimicrobial resistance research
- Innate immunity and host defense studies
- Wound healing mechanism research
- Biofilm disruption studies
- Inflammatory and autoimmune research

**DISCLAIMER:** LL-37 is for laboratory research use only. Not for human consumption.
    `
  }
];

export default function BlogGuide() {
  const [selectedPost, setSelectedPost] = React.useState(null);

  if (selectedPost) {
    const post = blogPosts.find(p => p.id === selectedPost);
    return (
      <div className="min-h-screen bg-white pt-32 pb-20">
        <SEO
          title={`${post.title} | Red Helix Research Blog`}
          description={post.excerpt}
          keywords={post.keywords}
        />
        <div className="max-w-4xl mx-auto px-4">
          <Button variant="outline" onClick={() => setSelectedPost(null)} className="mb-8 border-slate-200 text-slate-600 hover:text-slate-900 hover:bg-slate-50">
            ← Back to Blog
          </Button>
          <motion.article
            initial={{ opacity: 0, y: 20 }}
            animate={{ opacity: 1, y: 0 }}
            className="prose prose-slate max-w-none"
          >
            <div className="mb-8">
              <h1 className="text-4xl md:text-5xl font-black text-slate-900 mb-4">{post.title}</h1>
              <div className="flex items-center gap-4 text-slate-500 text-sm font-medium">
                <span>{post.date}</span>
                <span>•</span>
                <span>{post.readTime}</span>
              </div>
            </div>
            <div className="bg-slate-50 border border-slate-200 rounded-[32px] p-8 md:p-12 prose-headings:text-slate-900 prose-p:text-slate-600 prose-strong:text-slate-900 prose-a:text-[#dc2626] prose-code:text-[#dc2626] prose-pre:bg-slate-900 prose-table:border-slate-200 shadow-sm">
              {post.content.split('\n').map((line, idx) => {
                if (line.startsWith('# ')) return <h1 key={idx} className="text-3xl font-black mt-8 mb-6 text-slate-900 uppercase tracking-tight">{line.substring(2)}</h1>;
                if (line.startsWith('## ')) return <h2 key={idx} className="text-2xl font-bold mt-8 mb-4 text-slate-900 flex items-center gap-2">{line.substring(3)}</h2>;
                if (line.startsWith('### ')) return <h3 key={idx} className="text-xl font-bold mt-6 mb-3 text-slate-800">{line.substring(4)}</h3>;
                if (line.startsWith('**') && line.endsWith('**')) return <p key={idx} className="font-bold text-slate-900">{line.substring(2, line.length - 2)}</p>;
                if (line.startsWith('- ')) return <li key={idx} className="ml-4 text-slate-600 marker:text-[#dc2626]">{line.substring(2)}</li>;
                if (line.trim() === '') return <br key={idx} />;
                return <p key={idx} className="mb-4 text-slate-600 leading-relaxed">{line}</p>;
              })}
            </div>
          </motion.article>
        </div>
      </div>
    );
  }

  return (
    <div className="min-h-screen bg-white pt-32 pb-20">
      <SEO
        title="Research Peptide Guides & Education | Red Helix Research Blog"
        description="In-depth research guides on BPC-157, TB-500, Semaglutide, Tirzepatide, CJC-1295, Ipamorelin, GHK-Cu, PT-141, Selank, Semax, MOTS-c, Epithalon, and more. Evidence-based peptide education for researchers."
        keywords="peptide research guide, BPC-157 guide, TB-500 research, semaglutide protocol, tirzepatide guide, CJC-1295, ipamorelin, GHK-Cu, PT-141, selank, semax, MOTS-c, epithalon, peptide reconstitution, peptide education, research peptide blog"
      />
      <div className="max-w-6xl mx-auto px-4">
        <Link to={createPageUrl('Home')}>
          <Button variant="outline" className="mb-8 border-slate-200 text-slate-600 hover:text-slate-900 hover:bg-slate-50">
            <ArrowLeft className="w-4 h-4 mr-2" />
            Back to Home
          </Button>
        </Link>

        <motion.div initial={{ opacity: 0, y: 20 }} animate={{ opacity: 1, y: 0 }} className="mb-12">
          <h1 className="text-5xl md:text-6xl font-black text-slate-900 mb-4 uppercase tracking-tight">Research Guides & Education</h1>
          <p className="text-xl text-slate-500 font-medium">Comprehensive, evidence-based guides for peptide researchers</p>
        </motion.div>

        <div className="grid grid-cols-1 md:grid-cols-2 gap-6">
          {blogPosts.map((post, idx) => (
            <motion.div
              key={post.id}
              initial={{ opacity: 0, y: 20 }}
              animate={{ opacity: 1, y: 0 }}
              transition={{ delay: idx * 0.1 }}
              onClick={() => setSelectedPost(post.id)}
              className="bg-white border border-slate-200 hover:border-[#dc2626]/30 rounded-[32px] p-8 cursor-pointer transition-all hover:shadow-xl hover:shadow-red-900/5 group"
            >
              <div className="flex items-start gap-4 mb-6">
                <div className="p-4 bg-[#dc2626] rounded-2xl shadow-sm group-hover:scale-110 transition-transform duration-300">
                  <post.icon className="w-6 h-6 text-white" />
                </div>
                <div className="flex-1">
                  <h2 className="text-xl font-black text-slate-900 mb-2 leading-tight group-hover:text-[#dc2626] transition-colors">{post.title}</h2>
                  <div className="flex items-center gap-3 text-xs font-bold text-slate-400 uppercase tracking-wider mb-3">
                    <span>{post.date}</span>
                    <span>•</span>
                    <span>{post.readTime}</span>
                  </div>
                </div>
              </div>
              <p className="text-slate-600 text-sm leading-relaxed font-medium mb-6">{post.excerpt}</p>
              <div className="pt-6 border-t border-slate-100 flex items-center text-[#dc2626] font-bold text-sm uppercase tracking-wider group-hover:gap-2 transition-all">
                Read Full Guide <ArrowLeft className="w-4 h-4 ml-2 rotate-180" />
              </div>
            </motion.div>
          ))}
        </div>

        <motion.div
          initial={{ opacity: 0, y: 20 }}
          animate={{ opacity: 1, y: 0 }}
          transition={{ delay: 0.4 }}
          className="mt-12 bg-[#dc2626] rounded-[32px] p-10 text-center relative overflow-hidden"
        >
          <div className="absolute top-0 right-0 w-64 h-64 bg-white/10 rounded-full blur-3xl -mr-32 -mt-32 pointer-events-none" />
          <div className="relative z-10">
            <h2 className="text-2xl font-black text-white mb-3 uppercase tracking-tight">Need More Information?</h2>
            <p className="text-white font-medium mb-8 max-w-2xl mx-auto">Can't find what you're looking for? Contact our research support team for personalized guidance on protocols and methodologies.</p>
            <Link to={createPageUrl('Contact')}>
              <Button className="bg-white text-[#dc2626] hover:bg-red-50 font-bold px-8 py-6 rounded-full shadow-lg">
                Contact Research Support
              </Button>
            </Link>
          </div>
        </motion.div>
      </div>
    </div>
  );
}